Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > This board is now complete trash talk !

<< Previous

Bullboard Posts

Next >>

Comment by skier59on Jan 18, 2021 5:13pm

123 Views

Post# 32322588

RE:RE:RE:RE:RE:RE:This board is now complete trash talk !

Well atleast it looks like they won't be issuing options for this past year.

robertshaw wrote:

2b7f6fab wrote: TLT should be putting out a quarterly update by month end. I don't understand all the complaining about mgmt on this board. The study is being conducted by the hospitals and not mgmt. It is mgmt that has performed to get TLT into PH2 trials. That's quite an accomplishment if you ask me. Sure things have taken longer than any of us thought. Again that was due to covid, and bureaucratic foot dragging on study 1 approval, TLT would be $3 to $5 stock now if PH2 trial was performed with correct dosing from the start.

Day in and day out I read the constant belly aching on this board about mgmt but I don't see that these delays were mgmt fault.

But made wrong decision to dilute at dirty low levels (after great milestone achievement news) and care only about their own trough by issuing too many free option to themselves without caring long shareholders' value, and made fake promise of seeing J. V ("in the immediate future") yet never carried out for over 3 years, absolute their fault.